tm logo
ONCOHELIX
SEARCHED

on 03 Jul 2024

Last Applicant/ Owned by

ONCOHELIX INC.

605-999 8 St SWCalgary

ALBERTA

CA

T2R1J5

Serial Number

2243997 filed on 08th Mar 2023

Correspondent Address

(c/o Ogilvie LLP )2800 Stantec Tower10220 103 AvenueEdmonton

ALBERTA

CA

T5J0K4

ONCOHELIX

Trademark usage description

advisory services relating to gene therapy research; analysis of human tissues and stem cells for scientific research purposes; analysis of proteins f Read More

Classification Information


Class [042]
Advisory services relating to gene therapy research; analysis of human tissues and stem cells for scientific research purposes; analysis of proteins for scientific and medical research purposes; antibody profiling for scientific research purposes; biochemical research; biological therapeutic research services; biomedical research; consulting services in the field of genetic engineering; data automation and data collection using software to evaluate, analyze and collect clinical research data in the field of genomics; data automation and data collection using software to evaluate, analyze and collect molecular research data in the field of genomics; dna analysis services for scientific research purposes; DNA screening for scientific research purposes; DNA sequencing for medical research purposes; ex vivo gene therapy research; genetic mapping for scientific purposes; genetic testing for scientific research purposes; genotyping services for research or analysis purposes; laboratory research analysis in the field of genetic testing; preparation of biological samples for testing and analysis in research laboratories; testing and analysis of blood plasma, red blood cells, white blood cells, blood platelets for scientific research purposes; testing and analysis of goods being imported or exported for quarantine clearance purposes; testing of human tissues and stem cells for scientific research purposes; testing services in the field of immunopharmaceuticals; testing services in the field of vaccines


Classification kind code

12

Class [044]
Genetic counselling; genetic testing for medical purposes; information, advisory and consultancy services in the field of medical testing services; medical diagnostic testing, monitoring and reporting services; medical testing for diagnostic or treatment purposes; medical testing of urine, blood, hair follicles and breath; medical testing services; medical testing services relating to the diagnosis and treatment of disease; providing analysis, evaluation, and reporting of autoimmune disease test results to help healthcare professionals determine a patient's clinical diagnosis; providing analysis, evaluation, and reporting of autoimmune disease test results to help healthcare professionals determine the effectiveness of treatments and to revise future treatments; providing analysis, evaluation, and reporting of cancer test results to help healthcare professionals determine a patient's clinical diagnosis; providing analysis, evaluation, and reporting of cancer test results to help healthcare professionals determine the effectiveness of treatments and to revise future treatments; providing analysis, evaluation, and reporting of infection test results to help healthcare professionals determine a patient's clinical diagnosis; providing analysis, evaluation, and reporting of infection test results to help healthcare professionals determine the effectiveness of treatments and to revise future treatments; providing medical diagnostic and prognostic testing services; providing medical diagnostic testing for autoimmune diseases; providing medical diagnostic testing for cancer; providing medical diagnostic testing for infections; providing prognostic diagnostic testing for autoimmune diseases; providing prognostic diagnostic testing for cancer; providing prognostic diagnostic testing for infections


Classification kind code

12

Mark Details


Serial Number

2243997

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 22
on 03rd Jul 2024
Search Recorded
Submitted for opposition 20
on 03rd Jul 2024
Examiner's First Report
Submitted for opposition 30
on 08th Mar 2023
Filed
Submitted for opposition 1
on 08th Mar 2023
Created
Submitted for opposition 31
on 08th Mar 2023
Formalized